NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: ENSC 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: NGNE 21.95%
NASDAQ: KORE 21.95%
NASDAQ: MGN 21.95%
